If you’re confused about the growing landscape of weight loss drugs, here is a concise breakdown of their mechanisms, ...

Retatrutide is a triple agonist, meaning it targets three hormone receptor agonists: GLP-1, GIP and glucagon (GCG). It’s ...

The Peptide Co has launched a dedicated online hub for Australian researchers and wellness enthusiasts, consolidating access to three of the most studied peptides in current scientific literature – ...

Compounding of this drug is currently illegal under federal law in the U.S. However, buzz around the drug’s effectiveness has led many people to seek it out online from companies or platforms that ...

Medics have issued an urgent warning around an experimental weight loss medication which is currently undergoing clinical ...

President Donald Trump recently praised Eli Lily at a public event and called it “a great company” and highlighted its ...

It is definitely a strong contender.

A STAT News report said several clues pointed to the president being the unnamed 79-year-old man who received the drug.

Doctors warn of an "enormous" risk of overdose after testing of a popular unapproved weight loss peptide reveals the product had double the strength of what was listed on its label.

It isn't approved by the FDA, but we found an experimental weight-loss drug called retatrutide for sale at a local convenience store.

Shortages of the GLP-1 receptor agonists tirzepatide and semaglutide resolved in December 2024 and February 2025, ...

So, first of all, why would Eli Lilly want to launch a stock split? Companies generally execute such an operation after the ...